McKessson公司在Florida癌症专家子公司Core Ventures公司以2.49bn获得70%的股权。 McKesson Corp. acquires 70% stake in Core Ventures, a Florida Cancer Specialists subsidiary, for $2.49bn.

McKessson公司是一家药品分销公司,它同意在Florida癌症专家和研究所的子公司Core Ventures公司获得70%的股权,大约为2.49bn。 McKesson Corp., a pharmaceutical distribution company, has agreed to acquire a 70% stake in Core Ventures, a subsidiary of Florida Cancer Specialists & Research Institute, for approximately $2.49bn. 这遵循了McKessson对以社区为基础的肿瘤服务的战略重点,使公司能够使其专业服务多样化。 This follows McKesson's strategic focus on community-based oncology services, and enables the company to diversify its specialty services. Florida癌症专家将对核心风险公司保持少数兴趣,并继续独立运作。 Florida Cancer Specialists will retain a minority interest in Core Ventures, and continue to operate independently. 提供佛罗里达州FCS诊所的行政支持服务的Core Ventures将加入麦克森的美国瘤网络. Core Ventures, which provides administrative support services to FCS clinics across Florida, will join McKesson's US Oncology network.